Anavex Life Sciences Corp (AVXL)

[falconer66a]

First Wins?

...its all about “first to market”!

Yea, that's the presumption of some.

If so, Anavex can just now fold and go home. Biogen's Aduhelm was first to market with a "real" (ha) Alzheimer's therapy. In one or two years, when blarcamesine is finally approved for the disease, no one will want it. "Blarcamesine? No, I want grandma on Aduhelm. They were first in the game. Biogen wins."

Sure.